Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Meiji Seika Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1MEIJI SEIKA PHARMA CO., LTD. Tokyo JP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    MEIJI SEIKA PHARMA CO., LTD. Tokyo ...

    Contact Supplier
    • FDA
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Daunorubicin Hydrochloride

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    R1-CEP 2003-061 - Rev 02
    Valid
    Chemical
    2023-01-03
    662
    blank

    01

    MEIJI SEIKA PHARMA CO., LTD. Tokyo ...

    Japan
    2024 ACI Convention
    Not Confirmed
    arrow

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-061 - Rev 02 of Meiji Seika Pharma Co., Ltd. Tokyo Jp

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-061 - Rev 02 of Meiji Seika Pharma Co., Ltd. Tokyo Jp 1

    20

    Meiji Seika Pharma Co., Ltd. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Daunorubicin Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-061 - Rev 02

    This Chemical Type CEP, issued on January 03, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 662 associated with this CEP further emphasizes